BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25737613)

  • 1. Albumin-to-alkaline phosphatase ratio: a novel prognostic index for hepatocellular carcinoma.
    Chan AW; Chan SL; Mo FK; Wong GL; Wong VW; Cheung YS; Chan HL; Yeo W; Lai PB; To KF
    Dis Markers; 2015; 2015():564057. PubMed ID: 25737613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
    Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
    BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum WFA+ -M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Korenaga M; Mizokami M; Narimatsu H
    Liver Int; 2016 Feb; 36(2):293-301. PubMed ID: 26134114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy.
    Zhang F; Lu SX; Hu KS; Gan YH; Chen Y; Ge NL; Yang BW; Zhang L; Chen RX; Ren ZG; Yin X
    Int J Hyperthermia; 2021; 38(1):1-10. PubMed ID: 33400889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of dynamic albumin-to-alkaline phosphatase ratio in limited stage small-cell lung cancer.
    Li X; Li B; Zeng H; Wang S; Sun X; Yu Y; Wang L; Yu J
    Future Oncol; 2019 Mar; 15(9):995-1006. PubMed ID: 30644319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator for patients undergoing minimally invasive lung cancer surgery: Propensity score matching analysis using a prospective database.
    Li SJ; Lv WY; Du H; Li YJ; Zhang WB; Che GW; Liu LX
    Int J Surg; 2019 Sep; 69():32-42. PubMed ID: 31319230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
    World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients.
    Carr BI; Guerra V
    Int J Biol Markers; 2017 Oct; 32(4):e391-e396. PubMed ID: 28862714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Predictive Value of Albumin-to-Alkaline Phosphatase Ratio for Overall Survival of Hepatocellular Carcinoma Patients Treated with Trans-Catheter Arterial Chemoembolization Therapy.
    Chen ZH; Zhang XP; Cai XR; Xie SD; Liu MM; Lin JX; Ma XK; Chen J; Lin Q; Dong M; Wu XY; Wen JY; Xu RH
    J Cancer; 2018; 9(19):3467-3478. PubMed ID: 30310503
    [No Abstract]   [Full Text] [Related]  

  • 10. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment.
    Cho HJ; Kim SS; Ahn SJ; Park SY; Park JH; Kim JK; Wang HJ; Cheong JY; Cho SW
    Cytokine; 2015 Jun; 73(2):245-52. PubMed ID: 25797190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma.
    Choi GH; Kim GI; Yoo JE; Na DC; Han DH; Roh YH; Park YN; Choi JS
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1444-52. PubMed ID: 25791790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies.
    Cai X; Chen Z; Chen J; Ma X; Bai M; Wang T; Chen X; Wu D; Wei L; Li X; Lin Q; Wen J; Ruan D; Lin Z; Dong M; Wu X
    J Cancer; 2018; 9(1):189-197. PubMed ID: 29290785
    [No Abstract]   [Full Text] [Related]  

  • 13. High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation.
    Cho HJ; Kim JK; Nam JS; Wang HJ; Lee JH; Kim BW; Kim SS; Noh CK; Shin SJ; Lee KM; Cho SW; Cheong JY
    Clin Biochem; 2015 Nov; 48(16-17):1073-8. PubMed ID: 26129878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.
    Tateishi R; Yoshida H; Shiina S; Imamura H; Hasegawa K; Teratani T; Obi S; Sato S; Koike Y; Fujishima T; Makuuchi M; Omata M
    Gut; 2005 Mar; 54(3):419-25. PubMed ID: 15710994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of spontaneously ruptured hepatocellular carcinoma.
    Han XJ; Su HY; Shao HB; Xu K
    World J Gastroenterol; 2015 Jun; 21(24):7488-94. PubMed ID: 26139994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?
    An L; Yin WT; Sun DW
    BMC Cancer; 2021 Mar; 21(1):247. PubMed ID: 33685425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
    Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
    World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio in Hepatocellular Carcinoma Patients Treated with Liver Transplantation.
    Li H; Wang L; Chen L; Zhao H; Cai J; Yao J; Zheng J; Yang Y; Wang G
    J Cancer; 2020; 11(8):2171-2180. PubMed ID: 32127944
    [No Abstract]   [Full Text] [Related]  

  • 19. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
    Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
    PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
    OuYang HY; Xu J; Luo J; Zou RH; Chen K; Le Y; Zhang YF; Wei W; Guo RP; Shi M
    Hepatology; 2016 Apr; 63(4):1227-39. PubMed ID: 26660154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.